Pituitary dysfunction after blast traumatic brain injury The UK BIOSAP study

Pituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone replacement offers a therapeutic opportunity. Blast TBI (bTBI) from improvised explosive devices is commonly seen in soldiers returning from recen...

Full description

Saved in:
Bibliographic Details
Published inAnnals of neurology Vol. 74; no. 4; pp. 527 - 536
Main Authors Baxter, David, Sharp, David J., Feeney, Claire, Papadopoulou, Debbie, Ham, Timothy E., Jilka, Sagar, Hellyer, Peter J., Patel, Maneesh C., Bennett, Alexander N., Mistlin, Alan, McGilloway, Emer, Midwinter, Mark, Goldstone, Anthony P.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.10.2013
Subjects
Online AccessGet full text
ISSN0364-5134
1531-8249
1531-8249
DOI10.1002/ana.23958

Cover

Abstract Pituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone replacement offers a therapeutic opportunity. Blast TBI (bTBI) from improvised explosive devices is commonly seen in soldiers returning from recent conflicts. We investigated: (1) the prevalence and consequences of pituitary dysfunction following moderate to severe bTBI and (2) whether it is associated with particular patterns of brain injury. Nineteen male soldiers with moderate to severe bTBI (median age = 28.3 years) and 39 male controls with moderate to severe nonblast TBI (nbTBI; median age = 32.3 years) underwent full dynamic endocrine assessment between 2 and 48 months after injury. In addition, soldiers had structural brain magnetic resonance imaging, including diffusion tensor imaging (DTI), and cognitive assessment. Six of 19 (32.0%) soldiers with bTBI, but only 1 of 39 (2.6%) nbTBI controls, had anterior pituitary dysfunction (p = 0.004). Two soldiers had hyperprolactinemia, 2 had growth hormone (GH) deficiency, 1 had adrenocorticotropic hormone (ACTH) deficiency, and 1 had combined GH/ACTH/gonadotrophin deficiency. DTI measures of white matter structure showed greater traumatic axonal injury in the cerebellum and corpus callosum in those soldiers with pituitary dysfunction than in those without. Soldiers with pituitary dysfunction after bTBI also had a higher prevalence of skull/facial fractures and worse cognitive function. Four soldiers (21.1%) commenced hormone replacement(s) for hypopituitarism. We reveal a high prevalence of anterior pituitary dysfunction in soldiers suffering moderate to severe bTBI, which was more frequent than in a matched group of civilian moderate to severe nbTBI subjects. We recommend that all patients with moderate to severe bTBI should routinely have comprehensive assessment of endocrine function.
AbstractList Pituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone replacement offers a therapeutic opportunity. Blast TBI (bTBI) from improvised explosive devices is commonly seen in soldiers returning from recent conflicts. We investigated: (1) the prevalence and consequences of pituitary dysfunction following moderate to severe bTBI and (2) whether it is associated with particular patterns of brain injury.OBJECTIVEPituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone replacement offers a therapeutic opportunity. Blast TBI (bTBI) from improvised explosive devices is commonly seen in soldiers returning from recent conflicts. We investigated: (1) the prevalence and consequences of pituitary dysfunction following moderate to severe bTBI and (2) whether it is associated with particular patterns of brain injury.Nineteen male soldiers with moderate to severe bTBI (median age = 28.3 years) and 39 male controls with moderate to severe nonblast TBI (nbTBI; median age = 32.3 years) underwent full dynamic endocrine assessment between 2 and 48 months after injury. In addition, soldiers had structural brain magnetic resonance imaging, including diffusion tensor imaging (DTI), and cognitive assessment.METHODSNineteen male soldiers with moderate to severe bTBI (median age = 28.3 years) and 39 male controls with moderate to severe nonblast TBI (nbTBI; median age = 32.3 years) underwent full dynamic endocrine assessment between 2 and 48 months after injury. In addition, soldiers had structural brain magnetic resonance imaging, including diffusion tensor imaging (DTI), and cognitive assessment.Six of 19 (32.0%) soldiers with bTBI, but only 1 of 39 (2.6%) nbTBI controls, had anterior pituitary dysfunction (p = 0.004). Two soldiers had hyperprolactinemia, 2 had growth hormone (GH) deficiency, 1 had adrenocorticotropic hormone (ACTH) deficiency, and 1 had combined GH/ACTH/gonadotrophin deficiency. DTI measures of white matter structure showed greater traumatic axonal injury in the cerebellum and corpus callosum in those soldiers with pituitary dysfunction than in those without. Soldiers with pituitary dysfunction after bTBI also had a higher prevalence of skull/facial fractures and worse cognitive function. Four soldiers (21.1%) commenced hormone replacement(s) for hypopituitarism.RESULTSSix of 19 (32.0%) soldiers with bTBI, but only 1 of 39 (2.6%) nbTBI controls, had anterior pituitary dysfunction (p = 0.004). Two soldiers had hyperprolactinemia, 2 had growth hormone (GH) deficiency, 1 had adrenocorticotropic hormone (ACTH) deficiency, and 1 had combined GH/ACTH/gonadotrophin deficiency. DTI measures of white matter structure showed greater traumatic axonal injury in the cerebellum and corpus callosum in those soldiers with pituitary dysfunction than in those without. Soldiers with pituitary dysfunction after bTBI also had a higher prevalence of skull/facial fractures and worse cognitive function. Four soldiers (21.1%) commenced hormone replacement(s) for hypopituitarism.We reveal a high prevalence of anterior pituitary dysfunction in soldiers suffering moderate to severe bTBI, which was more frequent than in a matched group of civilian moderate to severe nbTBI subjects. We recommend that all patients with moderate to severe bTBI should routinely have comprehensive assessment of endocrine function.INTERPRETATIONWe reveal a high prevalence of anterior pituitary dysfunction in soldiers suffering moderate to severe bTBI, which was more frequent than in a matched group of civilian moderate to severe nbTBI subjects. We recommend that all patients with moderate to severe bTBI should routinely have comprehensive assessment of endocrine function.
Pituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone replacement offers a therapeutic opportunity. Blast TBI (bTBI) from improvised explosive devices is commonly seen in soldiers returning from recent conflicts. We investigated: (1) the prevalence and consequences of pituitary dysfunction following moderate to severe bTBI and (2) whether it is associated with particular patterns of brain injury. Nineteen male soldiers with moderate to severe bTBI (median age = 28.3 years) and 39 male controls with moderate to severe nonblast TBI (nbTBI; median age = 32.3 years) underwent full dynamic endocrine assessment between 2 and 48 months after injury. In addition, soldiers had structural brain magnetic resonance imaging, including diffusion tensor imaging (DTI), and cognitive assessment. Six of 19 (32.0%) soldiers with bTBI, but only 1 of 39 (2.6%) nbTBI controls, had anterior pituitary dysfunction (p = 0.004). Two soldiers had hyperprolactinemia, 2 had growth hormone (GH) deficiency, 1 had adrenocorticotropic hormone (ACTH) deficiency, and 1 had combined GH/ACTH/gonadotrophin deficiency. DTI measures of white matter structure showed greater traumatic axonal injury in the cerebellum and corpus callosum in those soldiers with pituitary dysfunction than in those without. Soldiers with pituitary dysfunction after bTBI also had a higher prevalence of skull/facial fractures and worse cognitive function. Four soldiers (21.1%) commenced hormone replacement(s) for hypopituitarism. We reveal a high prevalence of anterior pituitary dysfunction in soldiers suffering moderate to severe bTBI, which was more frequent than in a matched group of civilian moderate to severe nbTBI subjects. We recommend that all patients with moderate to severe bTBI should routinely have comprehensive assessment of endocrine function.
Author Feeney, Claire
Jilka, Sagar
Mistlin, Alan
Baxter, David
Ham, Timothy E.
McGilloway, Emer
Papadopoulou, Debbie
Hellyer, Peter J.
Bennett, Alexander N.
Goldstone, Anthony P.
Sharp, David J.
Patel, Maneesh C.
Midwinter, Mark
Author_xml – sequence: 1
  givenname: David
  surname: Baxter
  fullname: Baxter, David
  organization: Computational Cognitive and Clinical Neuroimaging Laboratory Division of Brain Sciences Imperial College London Hammersmith Hospital London, Royal Centre for Defence Medicine Academic Department of Military Surgery and Trauma Birmingham
– sequence: 2
  givenname: David J.
  surname: Sharp
  fullname: Sharp, David J.
  organization: Computational Cognitive and Clinical Neuroimaging Laboratory Division of Brain Sciences Imperial College London Hammersmith Hospital London
– sequence: 3
  givenname: Claire
  surname: Feeney
  fullname: Feeney, Claire
  organization: Computational Cognitive and Clinical Neuroimaging Laboratory Division of Brain Sciences Imperial College London Hammersmith Hospital London, Imperial Centre for Endocrinology Imperial College Healthcare NHS Trust Charing Cross Hospital London
– sequence: 4
  givenname: Debbie
  surname: Papadopoulou
  fullname: Papadopoulou, Debbie
  organization: Imperial Centre for Endocrinology Imperial College Healthcare NHS Trust Charing Cross Hospital London
– sequence: 5
  givenname: Timothy E.
  surname: Ham
  fullname: Ham, Timothy E.
  organization: Computational Cognitive and Clinical Neuroimaging Laboratory Division of Brain Sciences Imperial College London Hammersmith Hospital London
– sequence: 6
  givenname: Sagar
  surname: Jilka
  fullname: Jilka, Sagar
  organization: Computational Cognitive and Clinical Neuroimaging Laboratory Division of Brain Sciences Imperial College London Hammersmith Hospital London
– sequence: 7
  givenname: Peter J.
  surname: Hellyer
  fullname: Hellyer, Peter J.
  organization: Computational Cognitive and Clinical Neuroimaging Laboratory Division of Brain Sciences Imperial College London Hammersmith Hospital London
– sequence: 8
  givenname: Maneesh C.
  surname: Patel
  fullname: Patel, Maneesh C.
  organization: Imaging Department Imperial College Healthcare NHS Trust Charing Cross Hospital London
– sequence: 9
  givenname: Alexander N.
  surname: Bennett
  fullname: Bennett, Alexander N.
  organization: Defence Medical Rehabilitation Centre Headley Court, Epsom, Surrey
– sequence: 10
  givenname: Alan
  surname: Mistlin
  fullname: Mistlin, Alan
  organization: Defence Medical Rehabilitation Centre Headley Court, Epsom, Surrey
– sequence: 11
  givenname: Emer
  surname: McGilloway
  fullname: McGilloway, Emer
  organization: Defence Medical Rehabilitation Centre Headley Court, Epsom, Surrey
– sequence: 12
  givenname: Mark
  surname: Midwinter
  fullname: Midwinter, Mark
  organization: Royal Centre for Defence Medicine Academic Department of Military Surgery and Trauma Birmingham, Academic Section for Musculoskeletal Disease Chapel Allerton Hospital University of Leeds Leeds
– sequence: 13
  givenname: Anthony P.
  surname: Goldstone
  fullname: Goldstone, Anthony P.
  organization: Imperial Centre for Endocrinology Imperial College Healthcare NHS Trust Charing Cross Hospital London, Metabolic and Molecular Imaging Group Medical Research Council Clinical Sciences Centre Imperial College London Hammersmith Hospital London United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23794460$$D View this record in MEDLINE/PubMed
BookMark eNplUTlPwzAYtRCIHjDwB1BGGNL6ihsvSKjikirBALPl2A64SpxiO0j997i0RRzTN3zv0nsjcOg6ZwA4Q3CCIMRT6eQEE16UB2CICoLyElN-CIaQMJoXiNABGIWwhBByhuAxGGAy45QyOATlk429jdKvM70Ode9UtJ3LZB2Nz6pGhphFL_tWRquyykvrMuuWvV-fgKNaNsGc7u4YvNzePM_v88Xj3cP8epErQmHMsUGylExpWBSEQFRCXCmtqgpzpGvNJaFEQ8pUXc6I4dpQrpkyvNCMyaKsyRhcbXVXfdUarYxLeRqx8rZNoUUnrfj9cfZNvHYfguJUCUFJ4GIn4Lv33oQoWhuUaRrpTNcHgSjDhHFUbqDnP72-TfZ1JcB0C1C-C8GbWqjU3aaxZG0bgaDYDCLSIOJrkMS4_MPYi_7HfgJSwYzT
CitedBy_id crossref_primary_10_1080_17446651_2020_1733411
crossref_primary_10_1517_14728214_2015_1058358
crossref_primary_10_3389_fneur_2018_00072
crossref_primary_10_1007_s11102_014_0606_5
crossref_primary_10_1093_jnen_nlw035
crossref_primary_10_1016_j_sxmr_2022_06_002
crossref_primary_10_1007_s40719_015_0018_7
crossref_primary_10_1186_s13195_014_0064_3
crossref_primary_10_3389_fendo_2018_00008
crossref_primary_10_1002_jnr_24604
crossref_primary_10_1016_j_psyneuen_2015_02_008
crossref_primary_10_1007_s11356_023_29161_w
crossref_primary_10_4103_ajm_AJM_2_18
crossref_primary_10_1007_s11910_023_01263_5
crossref_primary_10_3758_s13415_016_0437_0
crossref_primary_10_3389_fneur_2020_541050
crossref_primary_10_1089_neu_2018_6349
crossref_primary_10_4158_EP15854_CO
crossref_primary_10_1136_jnnp_2016_315500
crossref_primary_10_1089_neu_2015_3998
crossref_primary_10_1089_neu_2014_3786
crossref_primary_10_1177_0091217420906659
crossref_primary_10_3390_ijms252413683
crossref_primary_10_1016_j_lfs_2020_118547
crossref_primary_10_1002_jnr_23408
crossref_primary_10_4236_ojemd_2014_41002
crossref_primary_10_1249_MSS_0000000000002892
crossref_primary_10_2519_jospt_2019_8926
crossref_primary_10_1007_s11102_018_0925_z
crossref_primary_10_1007_s11102_019_00958_8
crossref_primary_10_1007_s11102_019_00938_y
crossref_primary_10_4158_EP14567_DSCR
crossref_primary_10_1176_appi_ajp_2015_15060750
crossref_primary_10_1007_s11102_019_00941_3
crossref_primary_10_3390_diagnostics13020212
crossref_primary_10_1016_j_beem_2017_02_001
crossref_primary_10_1210_en_2018_00203
crossref_primary_10_1093_milmed_usae563
crossref_primary_10_1038_s41386_021_01138_8
crossref_primary_10_1016_j_lfs_2021_119722
crossref_primary_10_1007_s11102_019_00949_9
crossref_primary_10_1016_j_jpeds_2023_02_002
crossref_primary_10_1080_17446651_2020_1810561
crossref_primary_10_1002_ana_24971
crossref_primary_10_3389_fendo_2018_00176
crossref_primary_10_12968_hmed_2018_79_3_C34
crossref_primary_10_3390_jcm4071463
crossref_primary_10_3389_fbioe_2022_821169
crossref_primary_10_1210_er_2014_1065
Cites_doi 10.1016/S0079-6123(10)82005-9
10.3389/fneur.2012.00011
10.1056/NEJMoa1008069
10.1002/ana.410120610
10.1530/EJE-09-0601
10.1136/bmjopen-2011-000312
10.1016/j.psyneuen.2011.03.009
10.1089/neu.2009.0885
10.1530/EJE-11-0365
10.1523/JNEUROSCI.3647-07.2007
10.1159/000176051
10.1001/jama.298.12.1429
10.1038/nrn3407
10.1093/brain/awq347
10.1210/jc.2009-1134
10.1210/jc.2005-0504
10.7205/MILMED-D-09-00189
10.1210/jc.2009-0299
10.1210/jc.2010-0982
10.1038/jcbfm.2009.203
10.1089/neu.2007.0343
10.1089/neu.2006.0245
10.1126/scitranslmed.3003716
10.1523/JNEUROSCI.1163-11.2011
10.1001/jama.2012.14008
10.1046/j.1365-2265.2001.01169.x
10.1210/er.2009-0009
10.1002/da.20837
10.1111/cen.12043
10.1210/jc.2011-0179
10.1001/jama.294.19.2481
ContentType Journal Article
Copyright 2013 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of the American Neurological Association.
2013 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of the American Neurological Association 2013
Copyright_xml – notice: 2013 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of the American Neurological Association.
– notice: 2013 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of the American Neurological Association 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1002/ana.23958
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8249
EndPage 536
ExternalDocumentID PMC4223931
23794460
10_1002_ana_23958
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: G0701951
– fundername: Department of Health
  grantid: NIHR-RP-011-048
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OB
1OC
1ZS
23M
2QL
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEJM
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAYXX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBMB
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AEYWJ
AFAZI
AFBPY
AFFNX
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AHMBA
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJJEV
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CITATION
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
F00
F01
F04
F5P
F8P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
GOZPB
GRPMH
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KBYEO
KD1
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LXL
LXN
LXY
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.-
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SJN
SUPJJ
TEORI
UB1
V2E
V8K
V9Y
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
XJT
XPP
XSW
XV2
YOC
YQJ
ZGI
ZRF
ZRR
ZXP
ZZTAW
~IA
~WT
~X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c340t-2e1a8a6cd0553301802bcdcbb291dfd9a343d046cf873e9de49d6ce95d66a58f3
ISSN 0364-5134
1531-8249
IngestDate Thu Aug 21 18:29:38 EDT 2025
Fri Sep 05 09:44:23 EDT 2025
Mon Jul 21 06:05:07 EDT 2025
Thu Apr 24 22:54:59 EDT 2025
Tue Jul 01 02:24:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License http://creativecommons.org/licenses/by/3.0
2013 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of the American Neurological Association.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c340t-2e1a8a6cd0553301802bcdcbb291dfd9a343d046cf873e9de49d6ce95d66a58f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC4223931
PMID 23794460
PQID 1462369181
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4223931
proquest_miscellaneous_1462369181
pubmed_primary_23794460
crossref_citationtrail_10_1002_ana_23958
crossref_primary_10_1002_ana_23958
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-10-01
PublicationDateYYYYMMDD 2013-10-01
PublicationDate_xml – month: 10
  year: 2013
  text: 2013-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford, UK
PublicationTitle Annals of neurology
PublicationTitleAlternate Ann Neurol
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References e_1_2_8_28_1
e_1_2_8_29_1
Chesser GS (e_1_2_8_3_1) 2012
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
Tanielian T (e_1_2_8_4_1) 2008
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
Dam PS (e_1_2_8_35_1) 2005; 64
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
Webb SM (e_1_2_8_34_1) 2008; 31
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – ident: e_1_2_8_17_1
  doi: 10.1016/S0079-6123(10)82005-9
– ident: e_1_2_8_33_1
  doi: 10.3389/fneur.2012.00011
– ident: e_1_2_8_16_1
  doi: 10.1056/NEJMoa1008069
– ident: e_1_2_8_31_1
  doi: 10.1002/ana.410120610
– ident: e_1_2_8_8_1
  doi: 10.1530/EJE-09-0601
– volume: 64
  start-page: 109
  issue: 3
  year: 2005
  ident: e_1_2_8_35_1
  article-title: Neurocognitive function in adults with growth hormone deficiency
  publication-title: Horm Res
– ident: e_1_2_8_32_1
  doi: 10.1136/bmjopen-2011-000312
– ident: e_1_2_8_18_1
  doi: 10.1016/j.psyneuen.2011.03.009
– ident: e_1_2_8_2_1
  doi: 10.1089/neu.2009.0885
– volume-title: Invisible wounds of war: psychological and cognitive injuries, their consequences, and services to assist recovery
  year: 2008
  ident: e_1_2_8_4_1
– volume: 31
  start-page: 52
  year: 2008
  ident: e_1_2_8_34_1
  article-title: Measurements of quality of life in patients with growth hormone deficiency
  publication-title: J Endocrinol Invest
– ident: e_1_2_8_7_1
  doi: 10.1530/EJE-11-0365
– ident: e_1_2_8_14_1
  doi: 10.1523/JNEUROSCI.3647-07.2007
– ident: e_1_2_8_10_1
  doi: 10.1159/000176051
– ident: e_1_2_8_6_1
  doi: 10.1001/jama.298.12.1429
– ident: e_1_2_8_28_1
  doi: 10.1038/nrn3407
– ident: e_1_2_8_15_1
  doi: 10.1093/brain/awq347
– ident: e_1_2_8_23_1
  doi: 10.1210/jc.2009-1134
– ident: e_1_2_8_26_1
  doi: 10.1210/jc.2005-0504
– ident: e_1_2_8_13_1
  doi: 10.7205/MILMED-D-09-00189
– ident: e_1_2_8_24_1
  doi: 10.1210/jc.2009-0299
– ident: e_1_2_8_25_1
  doi: 10.1210/jc.2010-0982
– ident: e_1_2_8_29_1
  doi: 10.1038/jcbfm.2009.203
– ident: e_1_2_8_12_1
  doi: 10.1089/neu.2007.0343
– ident: e_1_2_8_20_1
  doi: 10.1089/neu.2006.0245
– ident: e_1_2_8_30_1
  doi: 10.1126/scitranslmed.3003716
– ident: e_1_2_8_36_1
  doi: 10.1523/JNEUROSCI.1163-11.2011
– ident: e_1_2_8_5_1
  doi: 10.1001/jama.2012.14008
– ident: e_1_2_8_21_1
  doi: 10.1046/j.1365-2265.2001.01169.x
– ident: e_1_2_8_27_1
  doi: 10.1210/er.2009-0009
– volume-title: Afghanistan casualties: military forces and civilians
  year: 2012
  ident: e_1_2_8_3_1
– ident: e_1_2_8_19_1
  doi: 10.1002/da.20837
– ident: e_1_2_8_22_1
  doi: 10.1111/cen.12043
– ident: e_1_2_8_11_1
  doi: 10.1210/jc.2011-0179
– ident: e_1_2_8_9_1
  doi: 10.1001/jama.294.19.2481
SSID ssj0009610
Score 2.3810701
Snippet Pituitary dysfunction is a recognized consequence of traumatic brain injury (TBI) that causes cognitive, psychological, and metabolic impairment. Hormone...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 527
SubjectTerms Adult
Anisotropy
Blast Injuries - complications
Brain Injuries - complications
Brain Injuries - epidemiology
Brain Injuries - etiology
Cognition Disorders - diagnosis
Cognition Disorders - etiology
Cohort Studies
Female
Humans
Male
Middle Aged
Military Personnel
Neuropsychological Tests
Original
Pituitary Diseases - epidemiology
Pituitary Diseases - etiology
Pituitary Diseases - psychology
Prevalence
Quality of Life
Severity of Illness Index
Young Adult
Subtitle The UK BIOSAP study
Title Pituitary dysfunction after blast traumatic brain injury
URI https://www.ncbi.nlm.nih.gov/pubmed/23794460
https://www.proquest.com/docview/1462369181
https://pubmed.ncbi.nlm.nih.gov/PMC4223931
Volume 74
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Li9swEIdFu4XSS-l70xdq6aEQnNqyLFu97S67bLuv0MaQm5EtmaYEO2Rt6Pav7-gRx2ly2PZigiKcoPkxGkmjbxD6EMcqDBiTHoXw26MqyD1OYuYlmi0nIMSXwtA-L9lpSr9Oo-m6GKe5XdLko-L3znsl_2NVaAO76luy_2DZ7qXQAJ_BvvAEC8PzVjYez5oW1vbLm6G8udYzVK_sdw5hcaMrQLQWyprrWhDDWfVTH5y7VIv0bHj45er7wbhHmd0CKxviZX_v_VD8ctU8egnxpgj7ctG1Dns71cpllB3NRS_XdgzTtKwXdTuvW-f58pnq70IE63y2teMMvIRY_OhI7Whz3tbW5HGqoj3XGVlGwJZLt4hYUYkRCbnFvG9isy-vspP0_DybHE8nd9E9UBoza-tva44YZxZLsfpDK8SUTz51L94MTLZWG38nzfaikMkj9NAtH_CB1cJjdEdVT9D9C5cg8RRddJLAPUlgIwlsJIE7SWAjCWwl8RmDIHB6hq0gsBHEM5SeHE-OTj1XMcMrQuo3HlGBSAQrpB_prGFN98sLWeQ54YEsJRchDaVPWVEmcai4VJRLVigeScZElJThc7RX1ZXaR1gHjpIW3C-JTwUEdglRBdWHtpyUStIB-rgarqxwOHld1WSeWRA2yWBkMzOyA_S-67qwDJVdnd6txjwDD6ePrUSl6vZaL05JyDiEogP0wtqgew0JYT6hzB-geMM6XQdNT9_8ppr9MBR1SjT9L3h5i999hR6sNf8a7TXLVr2BWLTJ3xqd_QHvLYwo
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pituitary+dysfunction+after+blast+traumatic+brain+injury%3A+The+UK+BIOSAP+study&rft.jtitle=Annals+of+neurology&rft.au=Baxter%2C+David&rft.au=Sharp%2C+David+J&rft.au=Feeney%2C+Claire&rft.au=Papadopoulou%2C+Debbie&rft.date=2013-10-01&rft.issn=1531-8249&rft.eissn=1531-8249&rft.volume=74&rft.issue=4&rft.spage=527&rft_id=info:doi/10.1002%2Fana.23958&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-5134&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-5134&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-5134&client=summon